Literature DB >> 29296879

Buccal epithelial cells display somatic, bone marrow-derived CALR mutation.

Scott R Gilles1, Linda B Baughn1,2, Matthew L Schomaker1, Elizabeth L Courville1, Andrew C Nelson1,3, Zohar Sachs3,4.   

Abstract

Buccal epithelial cells harbor an MPN-associated CALR mutation in a patient with CALR-mutant essential thrombocytosis, Ph+ CML, and no germ line CALR mutation.

Entities:  

Year:  2017        PMID： 29296879      PMCID： PMC5729632          DOI： 10.1182/bloodadvances.2017012229

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


  24 in total

1.  Differentiation of human bone marrow-derived cells into buccal epithelial cells in vivo: a molecular analytical study.

Authors:  Simon D Tran; Stanley R Pillemer; Amalia Dutra; A John Barrett; Michael J Brownstein; Sharon Key; Evgenia Pak; Rose Anne Leakan; Albert Kingman; Kenneth M Yamada; Bruce J Baum; Eva Mezey
Journal:  Lancet       Date:  2003-03-29       Impact factor: 79.321

2.  Co-existence of JAK2 V617F and CALR mutations in primary myelofibrosis.

Authors:  Lurdes Zamora; Blanca Xicoy; Marta Cabezón; Cristalina Fernandez; Silvia Marcé; Patricia Velez; Marisol Xandri; David Gallardo; Fuensanta Millá; Evarist Feliu; Concepción Boqué
Journal:  Leuk Lymphoma       Date:  2015-03-11

3.  A CALR mutation preceding BCR-ABL1 in an atypical myeloproliferative neoplasm.

Authors:  Xénia Cabagnols; Jean-Michel Cayuela; William Vainchenker
Journal:  N Engl J Med       Date:  2015-02-12       Impact factor: 91.245

4.  CALR-mutated essential thrombocythemia evolving to chronic myeloid leukemia with coexistent CALR mutation and BCR-ABL translocation.

Authors:  Irina Bonzheim; Barbara Mankel; Peter Klapthor; Janine Schmidt; Tanja Hinrichsen; Oliver Wachter; Falko Fend; Leticia Quintanilla-Martinez
Journal:  Blood       Date:  2015-04-02       Impact factor: 22.113

5.  Looking for CALR mutations in familial myeloproliferative neoplasms.

Authors:  M Maffioli; A Genoni; D Caramazza; B Mora; A Bussini; M Merli; T Giorgino; R Casalone; F Passamonti
Journal:  Leukemia       Date:  2014-01-20       Impact factor: 11.528

6.  Somatic mutations of calreticulin in myeloproliferative neoplasms.

Authors:  Thorsten Klampfl; Heinz Gisslinger; Ashot S Harutyunyan; Harini Nivarthi; Elisa Rumi; Jelena D Milosevic; Nicole C C Them; Tiina Berg; Bettina Gisslinger; Daniela Pietra; Doris Chen; Gregory I Vladimer; Klaudia Bagienski; Chiara Milanesi; Ilaria Carola Casetti; Emanuela Sant'Antonio; Virginia Ferretti; Chiara Elena; Fiorella Schischlik; Ciara Cleary; Melanie Six; Martin Schalling; Andreas Schönegger; Christoph Bock; Luca Malcovati; Cristiana Pascutto; Giulio Superti-Furga; Mario Cazzola; Robert Kralovics
Journal:  N Engl J Med       Date:  2013-12-10       Impact factor: 91.245

7.  Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation.

Authors:  Elisa Rumi; Francesco Passamonti; Matteo G Della Porta; Chiara Elena; Luca Arcaini; Laura Vanelli; Cecilia Del Curto; Daniela Pietra; Emanuela Boveri; Cristiana Pascutto; Mario Cazzola; Mario Lazzarino
Journal:  J Clin Oncol       Date:  2007-11-12       Impact factor: 44.544

8.  Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.

Authors:  Joseph Saliba; Cécile Saint-Martin; Antonio Di Stefano; Gaëlle Lenglet; Caroline Marty; Boris Keren; Florence Pasquier; Véronique Della Valle; Lise Secardin; Gwendoline Leroy; Emna Mahfoudhi; Sarah Grosjean; Nathalie Droin; M'boyba Diop; Philippe Dessen; Sabine Charrier; Alberta Palazzo; Jane Merlevede; Jean-Côme Meniane; Christine Delaunay-Darivon; Pascal Fuseau; Françoise Isnard; Nicole Casadevall; Eric Solary; Najet Debili; Olivier A Bernard; Hana Raslova; Albert Najman; William Vainchenker; Christine Bellanné-Chantelot; Isabelle Plo
Journal:  Nat Genet       Date:  2015-08-17       Impact factor: 38.330

9.  A Polycythemia Vera JAK2 Mutation Masquerading as a Duodenal Cancer Mutation.

Authors:  Justin Lee; Jennifer Axilbund; W Brian Dalton; Daniel Laheru; Stanley Watkins; David Chu; Karen Cravero; Berry Button; Kelly Kyker-Snowman; Ian Waters; Christopher D Gocke; Josh Lauring; Ben Ho Park
Journal:  J Natl Compr Canc Netw       Date:  2016-12       Impact factor: 11.908

10.  A TET2 rs3733609 C/T genotype is associated with predisposition to the myeloproliferative neoplasms harboring JAK2(V617F) and confers a proliferative potential on erythroid lineages.

Authors:  Xiao-hui Shen; Nan-nan Sun; Ya-fei Yin; Su-fang Liu; Xiao-liu Liu; Hong-ling Peng; Chong-wen Dai; Yun-xiao Xu; Ming-yang Deng; Yun-ya Luo; Wen-li Zheng; Guang-sen Zhang
Journal:  Oncotarget       Date:  2016-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.